American Well Corporation (AMWL) Analyst Forecast
Revenue and earnings estimates published by analysts covering American Well Corporation (AMWL), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For American Well Corporation, analysts forecast revenue falling from $246.57T in 2025 to $240.48T in 2030; the average estimate for 2030 earnings per share is $-0.26; with published estimates ranging from $-0.27 to $-0.25; 5 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD millions)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
American Well Corporation (AMWL) forecast — frequently asked questions
What is the analyst price target for American Well Corporation?
Analysts covering American Well Corporation (AMWL) have a consensus price target of $13.00, 3.4% below the current price of $13.46. Published targets range from $11.00 to $16.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for American Well Corporation's earnings?
The average analyst estimate for American Well Corporation (AMWL) earnings per share in 2030 is -0.26, with individual estimates between -0.27 and -0.25.
How much revenue is American Well Corporation expected to make?
Analysts forecast American Well Corporation (AMWL) revenue of $240.48T in 2030, based on 2 published estimates.
How many analysts cover AMWL?
5 analysts contribute estimates for American Well Corporation (AMWL). Thin coverage makes an average less reliable.
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.